Veracyte, Inc. (VCYT) is a publicly traded Healthcare sector company. As of September 1, 2026, VCYT trades at $42.99 with a market cap of $3.48B and a P/E ratio of 29.65. VCYT moved -0.46% today. Year to date, VCYT is +2.59%; over the trailing twelve months it is +42.35%. Its 52-week range spans $22.61 to $60.91. Analyst consensus is buy with an average price target of $57.75. Rallies surfaces VCYT's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Veracyte, Inc. (VCYT) research on Rallies includes live charts, financials, analyst ratings, hedge fund holdings, politician trades, insider activity, news, AI research, and community context. VCYT moved -0.46% today. Analyst consensus is buy.
| Metric | Value |
|---|---|
| Price | $42.99 |
| Market Cap | $3.48B |
| P/E Ratio | 29.65 |
| EPS | $1.44 |
| Dividend Yield | 0.00% |
| 52-Week High | $60.91 |
| 52-Week Low | $22.61 |
| Volume | 387.70K |
| Avg Volume | 0 |
| Revenue (TTM) | $561.90M |
| Net Income | $114.48M |
| Gross Margin | 71.71% |
9 analysts cover VCYT: 0 strong buy, 7 buy, 1 hold, 1 sell, 0 strong sell. Consensus rating is buy. Average price target: $57.75.